IEQ Capital’s GSK GSK Stock Holding History

IEQ Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.51M	Sell	47,975 -4,042	-8%	-$214K	0.01%	714
2026 Q1	$2.87M	Buy	52,017 +5,006	+11%	+$271K	0.01%	651
2025 Q4	$2.31M	Buy	47,011 +5,975	+15%	+$279K	0.01%	743
2025 Q3	$1.77M	Buy	41,036 +24,952	+155%	+$975K	0.01%	804
2025 Q2	$618K	Buy	16,084 +4,824	+43%	+$184K	﹤0.01%	1066
2025 Q1	$436K	Buy	11,260 +1,693	+18%	+$62K	﹤0.01%	1030
2024 Q4	$324K	Buy	9,567 +910	+11%	+$32.8K	﹤0.01%	997
2024 Q3	$354K	Buy	8,657 +2,569	+42%	+$105K	﹤0.01%	868
2024 Q2	$234K	Buy	6,088 +11	+0.2%	+$463	﹤0.01%	870
2024 Q1	$261K	Buy	+6,077	New	+$251K	﹤0.01%	801
2022 Q3	–	Sell	-4,075	Closed	-$222K	–	850
2022 Q2	$222K	Buy	+4,075	New	+$225K	0.01%	695

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

IEQ Capital's GSK Position: Q2 2026 in Review

IEQ Capital reduced its GSK (GSK) stake by 7.8% in Q2 2026, selling an estimated $214K and leaving 47,975 shares worth $2.51M. The position accounts for 0.01% of the portfolio, ranked #714.

IEQ Capital first reported a position in GSK in Q2 2022 and has held it in 11 quarters since. The position peaked at $2.87M in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

IEQ Capital held 47,975 shares of GSK worth $2.51M as of Q2 2026.
IEQ Capital sold 4,042 GSK shares in Q2 2026, an estimated $214K.
GSK made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #714 holding.
IEQ Capital first reported a position in GSK in Q2 2022 and has held it in 11 quarters since.
IEQ Capital's GSK position peaked at $2.87M in Q1 2026.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.